Publications
- 
                        Sentís I, Melero JL, Cebrià A, Grzelak M, Soto M, Michel A, Rovira Q, Rodriguez-Hernandez CJ, Caratù G, Urpi A, Sauvage C, Mendizabal-Sasieta A, Maspero D, Lavarino C, Pascual-Reguant A, Castañeda-Heredia A, Muñoz Perez JP, Mora J, Harari A, Nieto JC, Avgustinova A and Heyn H. Spatiotemporal T-cell tracking for personalized T-cell receptor T-cell therapy designs in childhood cancerANNALS OF ONCOLOGY . 36(9): 1096-1106. 
- 
                        Keck MK, Al-Hussaini M, Amayiri N, Yiadom AAB, Chamyan G, Cheesman E, Faure-Conter C, Garcia-Ariza M, Gauchotte G, Hasselblatt M, Jorgensen M, Kilday JP, Lamas G, Lavarino C, Li MM, Lubieniecki F, Maher OM, Meyronet D, Mueller J, Santi M, Schüller U, Seidinger AL, Sill M, Sudhakar S, García MT, Tauziede-Espariat A, Varlet P, Vasiljevic A, Wittmann A, von Deimling A, Solomon DA, Sahm F, Tietze A, von Hoff K, Sievers P and Jones DTW. PLAG1 fusions define a third subtype of CNS embryonal tumor with PLAG family gene alteration.ACTA NEUROPATHOLOGICA . 150(1): 12-12. 
- 
                        Balaguer-Lluna L, Gene-Olaciregui N, Aschero MR, Resa-Parés C, Paco-Mercader S, Cuadrado-Vilanova M, Burgeño-Sandoval V, Baulenas-Farrés M, Monterrubio C, Manzanares-Quintela A, Rodriguez E, Lavarino C, Mora J and Carcaboso AM. Establishment of xenografts and methods to evaluate tumor burden for the three most frequent subclasses of pediatric-type diffuse high grade gliomasJOURNAL OF NEURO-ONCOLOGY . 172(3): 599-611. Number of citations: 2 
- 
                        Zhang D, Sánchez-Espino LF, Ivars M, Pope E, Nopper AJ, Arkin LM, Tollefson MM, Lavarino C, Muldowney M, Gene-Olaciregui N, Paco-Mercader S, Drolet BA and Baselga E. Phenotypic Spectrum of GNA11 R183C MosaicismPEDIATRIC DERMATOLOGY . 42(3): 475-480. Number of citations: 1 
- 
                        Cristina Larrosa Espinosa, Simao-Rafael M, Salvador-Marcos N, Muñoz JP, Lavarino C, Chantada G and Mora J. Case Report: Successful treatment of metastatic retinoblastoma with CNS involvement with anti-GD2 immunotherapy, intrathecal topotecan and reduced systemic chemotherapyFrontiers in pediatrics . 12: 1509645-1509645. Number of citations: 2 
- 
                        Baulenas-Farrés M, Paco-Mercader S, Marino F, Mohr J, Panisello C, Balaguer-Lluna L, Aschero MR, Cuadrado-Vilanova M, Resa-Parés C, Rodriguez E, Márquez-Pereira JM, Menéndez P, Jou-Munoz C, Benítez R, Benitez-Ribas D, Lavarino C, Mora J and Carcaboso AM. Proteins of the cancer cell secretome induce the protumoral microenvironment of diffuse intrinsic pontine gliomaneuro-oncology advances . 7(1): . 
- 
                        Planas-Roman S, Salvador-Marcos N, Lavarino C, Zuccarino F, Pereda D, Muñoz JP and Aurensanz E. Hamartoma of mature cardiac myocytes presenting as a polypoid epicardial tumor in the interatrial groove and with gene fusions by copy number anomalies of chromosome 7CARDIOVASCULAR PATHOLOGY . 73: 107660-107660. Number of citations: 2 
- 
                        Chirica M, Jurmeister P, Teichmann D, Koch A, Perez E, Schmid S, Simon M, Driever PH, Bodden C, van Tilburg CM, Hardin EC, Lavarino C, Hench J, Scheie D, Cryan J, Vicha A, Buttarelli FR, Michiels A, Haberler C, Barahona P, Tops BBJ, Jacques T, Stokland T, Witt O, Jones DTW and Capper D. DNA methylation-array interlaboratory comparison trial demonstrates highly reproducible paediatric CNS tumour classification across 13 international centresNEUROPATHOLOGY AND APPLIED NEUROBIOLOGY . 50(5): . 
- 
                        Sánchez-Espino LF, Ivars M, Prat-Torres CS, Lavarino C, Gene-Olaciregui N, Rovira-Zurriaga C, Celis-Passini V, Miguel Bejarano Serrano and Baselga E. Single dominant lesion in capillary malformation-arteriovenous malformation (CM-AVM) RASA1 syndromePEDIATRIC DERMATOLOGY . 41(5): 861-865. Number of citations: 1 
- 
                        Sanchez-Guixe E, Muiños F, Pinheiro-Santin M, González-Huici V, Rodriguez-Hernandez CJ, Avgustinova A, Lavarino C, González- Pérez A, Mora J and López-Bigas N. Origins of Second Malignancies in Children and Mutational Footprint of Chemotherapy in Normal TissuesCANCER DISCOVERY . 14(6): 953-964. Number of citations: 7 
